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Abstract
Cancer associated fibroblasts (CAFs) are responsible for tumor growth, angiogenesis, invasion, and metastasis. Matrix
metalloproteinase (MMP)-9 secreted from cancer stroma populated by CAFs is a prerequisite for cancer angiogenesis and
metastasis. Omega-3 polyunsaturated fatty acids (omega-3 PUFA) have been reported to have anti-tumor effects on diverse
types of malignancies. Fat-1 mice, which can convert omega-6 to omega-3 PUFA independent of diet, are useful to
investigate the functions of endogenous omega-3 PUFA. To examine the effect of omega-3 PUFA on tumorigenesis, TC-1
cells, a murine epithelial cell line immortalized by human papillomavirus (HPV) oncogenes, were injected subcutaneously
into fat-1 or wild type mice. Tumor growth and angiogenesis of the TC-1 tumor were significantly suppressed in fat-1
compared to wild type mice. cDNA microarray of the tumors derived from fat-1 and wild type mice revealed that MMP-9 is
downregulated in fat-1 mice. Immunohistochemical study demonstrated immunoreactivity for MMP-9 in the tumor stromal
fibroblasts was diffusely positive in wild type whereas focal in fat-1 mice. MMP-9 was expressed in primary cultured
fibroblasts isolated from fat-1 and wild type mice but was not expressed in TC-1 cells. Co-culture of fibroblasts with TC-1
cells enhanced the expression and the proteinase activity of MMP-9, although the protease activity of MMP-9 in fat-1-
derived fibroblasts was lower than that in wild type fibroblasts. Our data suggests that omega-3 PUFAs suppress MMP-9
induction and tumor angiogenesis. These findings may provide insight into mechanisms by which omega-3 PUFAs exert
anti-tumor effects by modulating tumor microenvironment.
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Introduction
The tumor microenvironment is comprised of microvascular
endothelial cells, adjacent normal epithelial cells and cancer-
associated fibroblasts (CAFs), and is reported to be an important
regulator of tumorigenesis [1,2]. As the most common cellular
population found in the tumor microenvironment, CAFs are
responsible for the synthesis of proteins involved in the remodeling
of the extracellular matrix (ECM), and for the secretion of growth
factors and cytokines that regulate tumor cell proliferation and
invasion [3,4]. In murine ovarian cancer xenograft models, the
p53/NF-kB pathway in CAFs significantly increased in vivo tumor
growth [5]. In colon cancer, Zhu Y et al. report that IL-1b
increased colon cancer cell proliferation and invasion by up-
regulating COX-2 signaling in CAFs [6].
Matrix-metalloproteinases (MMPs) are synthesized as proen-
zymes and typically activated by proteolytic removal of a
propeptide [7]. MMPs are reported to influence tumor progression
by facilitating events pivotal for neovascularization and establish-
ment of distant metastasis including proliferation, survival and
migration of endothelial, tumor and stromal cells [8,9]. MMP-2
and MMP-9 are implicated as prerequisites for angiogenesis and
metastasis in the carcinogenesic process. MMP-2 is expressed in
the various cancer cell lines [10]. In contrast, MMP-9 has very
limited or no expression in these cancer cells. Instead, MMP-9 is
well-known to be secreted from cancer stromal fibroblasts and
endothelial cells [11,12]. MMP-9 is a member of a family of zinc
containing endoproteinases that is involved in degradation of
extracellular matrix (ECM) and in vascular remodeling [13].
Docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic
acid (EPA, 20:5n-3) are representative mediators of omega-3
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polyunsaturated fatty acids (omega-3 PUFAs) and exert anti-
inflammatory effects in acute and chronic pathological inflamma-
tory reactions by counteracting inflammation [14]. Omega-3
PUFAs are also reported to have anti-cancer effects based on in
vitro and vivo studies [15–17]. Several mechanisms have been
proposed to explain the anti-cancer effects of omega-3 PUFAs.
Omega-3 PUFAs alter the growth of tumor cells by modulating
cell replication, by interfering with components of the cell cycle or
by increasing cell death via necrosis or apoptosis [18,19]. Omega-
3 PUFAs are also known to exert anti-angiogenic effects by
inhibiting the production of many angiogenic mediators including:
vascular endothelial growth factor (VEGF), platelet-derived
growth factor (PDGF), and prostaglandin E2 (PGE2) [20–24].
Dietary supplementation is a traditional approach to modify
tissue nutrient composition in animal studies of nutrition. Feeding
animals diets that alter specific nutritional and non-nutritional
components can help to differentiate experimental groups;
however, it can be exceedingly difficult to provide diets that are
identical in all but a single or a small but controlled number of
components. Kang et al. recently engineered a transgenic mouse
that carries the fat-1 gene from the roundworm Caenorhabditis
elegans [25]. This gene encodes an omega-3 fatty acid desaturase
that catalyzes the conversion of omega-6 to omega-3 PUFAs and
that is absent in most animals, including mammals. There is a
remarkable difference in the tissue omega-6/omega-3 PUFA ratio
between wild type and fat-1 transgenic mice [26]. Fat-1 mice,
which typically exhibit a balanced ratio of omega-6 to omega-3
PUFAs in their tissues and organs independent of diet, allow
carefully controlled studies to be performed in the absence of
potential confounding factors of diet. This makes them a useful
model to investigate the biological properties of endogenous
omega-3 PUFAs [25]. Several reports using fat-1 mice have
demonstrated anti-cancer effects of omega-3 PUFAs [27–30]. In
these investigations, omega-3 PUFAs exerted anti-cancer effects by
suppressing inflammatory reactions and PGE2 secretion from
cancer cells. To date, there are few studies that investigate the
involvement of omega-3 PUFAs in the biology of CAFs.
In this study, we hypothesized that omega-3 PUFAs may alter
tumor microenvironments by influencing CAF activity. To
examine this hypothesis, fibroblasts derived from fat-1 and wild
type mice were assessed both in vitro and in vivo under conditions
allowing interaction with TC-1 cancer cells. TC-1 cells were
derived from the epithelium of C56BL/6 mice and immortalized
by human papillomavirus (HPV) type 16 E6 and E7 oncoproteins.
They are commonly used in vitro and in vivo in murine models of
HPV-related cancer [31]. Here, we investigated the involvement
of omega-3 PUFAs in TC-1 tumorigenesis by comparing fat-1 and
wild type mice. Our specific focus involved the study of tumor-
associated fibroblasts. These models are useful in the study of
CAFs because the cancer cells originate in wild type murine
epithelium while the cancer stromal components, including CAFs,
come from fat-1 (omega-3 PUFAs-rich) or wild type (normal
PUFAs) mice.
Materials and Methods
Animals and diet
Fat-1 mice were created on a C57BL/6 background as
described [26] and subsequently backcrossed (at least four times)
onto a C57BL/6 background. Animals were fed a special diet
(AIN-76A+10% safflower oil; CLEA Japan, Inc.) that contained
10.3% total fat with fatty acid composition of C16:0 (7.6%), C18:0
(2.7%), C18:1n-9 (14.1%), C18:2n-6 (73.2%), C18: 3n-3 (0.3%),
C20:4n-6 (,0.1%), C20:5n-3 (,0.1%), C22: 6n-3 (,0.1%), high
in n-6 and low in n-3 fatty acids, until the desired age (6–8 weeks)
for experiments. To prevent the oxidation of lipids in the diet, all
foods were stored in the refrigerator with antioxidants (AGELESS;
Mitsubishi Gas Chemical Inc.), and prepared newly every two
days. Animal studies were approved by the University of Tokyo
Animal Committee.
Tumor growth assay in mice
TC-1 cells are derived from a primary lung epithelial cell from
C56BL6/mice and immortalized using HPV 16 E6/E7 plus c-
Has-ras (kind gift from Dr. T. C. Wu, Johns-Hopkins University,
Baltimore MD USA) [32]. TC-1 cells were cultured in DMEM
(Gibco, NY, USA) containing 10% FBS, 100 U/ml penicillin,
0.1 mg/ml streptomycin, and 0.25 g/ml amphotericin B. Eight-
week-old female mice were injected with 56106 murine TC-1 cells
suspended in 100 ml of DMEM. Tumor volume, based on caliper
measurements, was calculated at 7 and 14 days after injection
according to the following formula: (tumor volume) = 1/26(the
shortest diameter) 26(the largest diameter). Mice were sacrificed
14 days after inoculation, tumors were excised and stored at
280uC for future analyses.
cDNA microarray
Total RNA from TC-1 tumors (above) was extracted using an
RNeasy minikit (QIAGEN, Hilden, Germany). For the cDNA
microarray analysis, 0.5 mg of pooled total RNA was amplified
and labeled using an Amino Allyl MessageAmpTM II mRNA
Amplification kit (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s instructions. Each sample of
mRNA labeled with Cy3 and reference mRNA labeled with Cy5
was cohybridized to the GeneTM Mouse Oligo chip 24 k (Toray
Industries Inc., Tokyo, Japan) at 37uC for 16 h. After hybridiza-
tion, each DNA chip was washed and dried. Hybridization signals
derived from Cy3 and Cy5 were scanned using Scan Array
Express (PerkinElmer, Waltham, MA, USA). The scanned image
was analyzed using GenePix Pro (MDS Analytical Technologies,
Sunnyvale, CA, USA). All analyzed data were scaled by global
normalization. GEO accession number is GSE54079.
Immunohistochemistry
Paraffin sections (4 mm) of TC-1 tumors were dewaxed in
xylene and rehydrated through graded ethanol to water. Antigens
were retrieved by boiling in 10 mM citrate buffer (pH 6.0) for
30 min. The cooled sections were incubated in DAKO REAL
Peroxidase-Blocking solution (DAKO, Carpinteria, CA, USA) for
10 min to quench endogenous peroxidase. To block nonspecific
binding, sections were incubated in DAKO Protein Blocking
solution (DAKO) for 10 min at room temperature. Sections were
then incubated with a rabbit polyclonal antibody against mouse
MMP-9 (PAB12714, Abnova, 1:100 dilution) in DAKO REAL
Antibody Diluent (DAKO) overnight at 4uC. The slides were
incubated for 1 hour at room temperature with peroxidase-
conjugated secondary antibodies, washed, incubated with DAB,
counterstained with hematoxylin, dehydrated through an ethanol
series and xylene, and mounted. To evaluate tumor microvessel
formation, tumor sections were stained for CD-31 using a rat
monoclonal antibody against mouse CD-31 (ab56299, Abcam,
Tokyo, Japan, 1:100 dilution).
RT-quantitative PCR (RT-qPCR)
Total RNA was extracted from TC-1 tumors and cultured
fibroblasts using an RNeasy minikit (QIAGEN, Hilden, Ger-
many), followed by reverse transcription. cDNA was amplified for
MMP-9 in CAFs Is Suppressed by Omega-3 PUFAs
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40 cycles in a Light Cycler 480 (Roche, Basel, Switzerland) using a
Universal Probe Master Mix and the following primers and
Universal Probe Library (UPL) probes (Roche). The primer pairs
and the universal probes corresponding to the each primer that
were used in amplifications were as follows: mouse b-actin, 59-
ATTGAAACATCAGCCAAGACC-39 and 59-CCGAATCTCA-
CGGACTAGTGT-39 probe88; mouse MMP-9, 59-ACGACA-
TAGACGGCATCCA-39 and 59-GCTGTGGTTCAGTTGTG-
GTG-39 probe19. Expression of MMP-9 was normalized using b-
actin mRNA as an internal standard. Expression levels were
calculated by the comparative Ct method using b-actin as an
endogenous reference gene.
Primary fibroblast culture and co-culture with TC-1 cells
Lungs were isolated from fat-1 transgenic and wild type mice
and washed with saline to remove blood cells. Isolation and culture
of pulmonary fibroblasts were performed using methods described
previously [33]. Lung tissues were minced into small pieces and
incubated in DMEM (Gibco, NY, USA) containing type I
collagenase (0.25%; Sigma-Aldrich, St Louis, MO, USA) and
deoxynuclease I (15 U/ml; TaKaRa, Tokyo, Japan) for 120 min
at 37uC. The resultant dispersed cells were separated by filtration
through nylon cell strainers (70 mm, BD, Franklin Lakes, NJ,
USA). Fibroblasts in the filtrate were collected, placed into 10 cm
dishes in DMEM containing 10% FBS, 100 U/ml penicillin,
0.1 mg/ml streptomycin, and 0.25 mg/l amphotericin B, and
incubated for 7–10 days. Fibroblasts were purified from other cell
population by differential adhesion and serial passage.
Confluent fibroblasts and TC-1 cells were trypsinized and
resuspended in DMEM containing 10% FBS, 100 U/ml penicil-
lin, 0.1 mg/ml streptomycin, and 0.25 g/ml amphotericin B and
16105 cells/ml cells of each cell type were plated together in 12
well culture plates. Co-cultures were incubated at 37uC 5% CO2
in a humidified atmosphere for 24 hours. Homotypic cultures
served as controls.
Gelatin zymography
Gelatin zymography assays were performed using a Gelatin
zymography kit (Cosmobio, Sapporo, Japan) according to the
manufacture’s instuctions. Cell culture supernatants were collected
and centrifuged at 1,500 rpm for 5 minutes. The cell free
supernatant was mixed with 26sample buffer and electrophoresed
using precast gels (10% polyacrylamide, 0.1% gelatin) at 4uC for 1
hour. Subsequentnzymatic reactions were performed at 37uC
overnight. Gelatinase activities were visualized using specific
staining solutions and destained in acetic acid-methanol-dH2O
(1:3:6). For semi-quantitative analyses, gelatin zymography bands
were analyzed using image analysis software (ImageJ).
Statistical analysis
Data are presented as means 6 SEM. Statistical analyses were
carried out by Student’s t-test, or Wilcoxon analysis using JMP
software. A value of P,0.05 was considered significant. In the
figure legends, asterisks indicate those comparisons with statistical
significance (p,0.05).
Results
Tumor growth and angiogenesis of TC-1 tumors is
suppressed in fat-1 mice
To investigate the effect of omega-3 PUFAs on cervical cancer
tumorigenesis, we injected TC-1 cells subcutaneously into fat-1
and the litter-mate wild type C57/BL6 mice. TC-1 tumor
formation rates and tumor growth were assessed by the number
of mice forming tumors and three-dimension tumor sizes,
respectively. There was no difference in tumor formation rates
between fat-1 and wild type mice. TC-1 tumor sizes were plotted
for 14 days in fat-1 and wild-type controls (Fig. 1). Tumor growth
rates were consistently lower in fat-1 mice when compared to wild
type mice at all time points. In fat-1 mice, tumor size at 14 days
after injection was significantly smaller than in wild-type controls
(Fig. 1). Although cell growth of TC-1 cells is dependent on
HPV16 E6/E7 expression, E6 and E7 expression in TC-1 tumors
was not downregulated in fat-1 mice (Fig. S1).
To further delineate mechanisms behind these differences in
tumor growth in this model, particularly in terms of the possible
role of host-derived cancer-associated stromal components includ-
ing CAFs, we next examined whether omega-3 PUFAs modified
angiogenesis in TC-1 tumor. We assessed semi-quantitatively
tumor microvessel density in TC-1 tumors derived from fat-1 and
wild type mice by counting the number of CD31-positive
microvessels in immunohistochemical assay (Fig. 2A and 2B).
CD31 immunostaining of TC-1 tumors derived from fat-1 and
wild type mice (Fig. 2A) demonstrated hypovascularity of the fat-1-
derived TC-1 tumors when compared with wild type-derived
tumors. The number of CD31-positive microvessels per high-
power field in fat-1 mice was significantly lower than that in wild
type mice (Fig. 2B). These in vivo data indicated that TC-1 tumor
growth and angiogenesis were at least suppressed in fat-1 mice
when compared with wild type counterparts although it was
difficult to accurately estimate TC-1 cell growth in fat-1 mice.
MMP-9 is downregulated in fat-1 mice-derived TC-1
tumors
To investigate potential differences in gene expression profiles of
TC-1 tumors growing in the skin of fat-1 and wild type mice, TC-1
tumor tissues obtained from fat-1 and wild type mice were
analyzed by cDNA microarray. Since omega-3 PUFAs are
reported to influence cell proliferation and inflammation, Table 1
lists relative gene expression levels for representative genes
associated with the tumor growth and inflammation (Table 1).
With the exception of EGF, expression levels of almost all
inflammatory cytokines/chemokines and growth factors in TC-1
Figure 1. Tumor growth rates in fat-1 and wild type (WT) mice.
56106 murine TC-1 cells suspended in 100 ml of DMEM were injected
s.c. into each of 10 fat-1 and wild type mice. Tumor volume, based on
caliper measurements, was calculated at 7 and 14 days after injection
according to the following formula: (tumor volume) = 1/26(the shortest
diameter) 26(the largest diameter). Mean values with standard
deviations are presented. Asterisks indicate those comparisons (fat-1
vs. wild type mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0089605.g001
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tumors from fat-1 mice were higher than those, in tumors from
wild-type controls. This suggested that anti-inflammatory and anti-
cell growth effects of omega-3 PUFAs are unlikely to be central to
their anti-tumor activities, at least in this model. We next
examined the expression of MMPs in these TC-1 tumors to
further address stroma-related angiogenesis in the tumor micro-
environments (Table 1). cDNA microarray demonstrated that the
expression of MMP-2 and -9 were suppressed in fat-1 mice-
derived TC-1 tumor while those of other MMPs were tended to be
upregulated when compared to controls. To confirm these effects
at the RNA level, RT-qPCR for MMP-9 was performed. MMP-9
RNA levels in fat-1 mice were approximately 60% lower than
those in wild type controls (Fig. 3A). TC-1 tumor immunohisto-
chemistry confirmed these results at the protein level. MMP-9
immunoreactivity in wild type mouse-derived TC-1 tumors was
clearly stronger than fat-1 mouse-derived tumors (Fig. 3B). High
power histochemical analysis of MMP-9 immnoreactivity in TC-1
cells (Fig. 3B, inserts) revealed negligible expression, while that of
the stromal components including CAFs and endothelial cells was
strongly positive only in the wild type-derived TC-1 tumors. These
data indicated that the production of MMP-9 in CAFs and
endothelial cells was clearly suppressed in fat-1 mice.
MMP-9 expression and gelatinase activity were
suppressed in cultured primary fibroblasts derived from
fat-1 mice
To mimic the cancer stromal microenvironment in vitro, we co-
cultured fibroblasts isolated from fat-1 and wild type mice with
TC-1 cells. We used lung tissues from fat-1 and wild type mice as
the sources for fibroblasts, and differential adhesion methodology
for their isolation. All fibroblasts were passaged 3–4 times prior to
use in experiments. Baseline MMP-9 expression levels in primary
fibroblasts from fat-1 mice were approximately 60% lower than
those from wild type-derived fibroblasts (Fig. 4A). Culture
Figure 2. Omega-3 PUFAs suppress tumor vasculogenesis.
CD31 immunostaining of the TC-1 tumor derived from wild type (WT)
mice (A) and fat-1 (B). Bars indicate 200 mm. (C) Microvessel densities in
TC-1 tumors are expressed as the representative number of labeled
vessels in 4 fields (n = 5). Mean values with standard deviations are
presented. Asterisks indicate those comparisons (fat-1 vs. wild type
mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0089605.g002
Figure 3. MMP-9 expression is downregulated in TC-1 tumors
from fat-1 mice. Total RNA was extracted from TC-1 tumors, followed
by reverse transcription. MMP-9 mRNA levels were measured by qRT-
PCR. Expression levels of MMP-9 were normalized to b-actin as an
internal standard (n = 4 in each group). Asterisks indicate those
comparisons (fat-1 vs. wild type (WT) mice) with statistical significance
(p,0.05). MMP-9 immunostaining of TC-1 tumors derived from wild
type (WT) and fat-1 mice. Bars indicate 200 mm in low-power fields,
50 mm in high-power fields.
doi:10.1371/journal.pone.0089605.g003
Table 1. Cytokine, growth factor, and MMP gene expression
comparisons in TC-1 tumors from fat-1 vs wild type mice.
Genes fat-1/WT ratio
EGF 0.4
CXCL-12 1.2
HGF 1.3
TGF-a 1.4
IL-6 2.0
IFN-c 2.4
TNF-a 3.3
VEGF 3.7
IL-1b 12.0
MMP-9 0.4
MMP-2 0.6
MMP-7 1.9
MMP-1b 2.9
MMP-3 2.9
MMP-13 2.9
MMP-1a 3.6
MMP-16 4.1
MMP-10 11.6
doi:10.1371/journal.pone.0089605.t001
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supernatants from each primary fibroblast subtype were collected
and subjected to polyacrylamide gel electrophoresis to examine
differences in MMP gelatinase activities (Fig. 4B). Using this
method, MMP-2 was detected but MMP-9 was not in both fat-1
and wild type fibroblast
Next, these primary fibroblasts were co-cultured with TC-1 cells
to examine fibroblasts activation upon in vitro exposure to cancer
cells 11. Fibroblasts and TC-1 cells were co-cultured for 24 hours
and MMP-9 transcription was measured by RT-qPCR. Fibro-
blasts from fat-1 and from wild type mice increased demonstrated
MMP-9 expression upon exposure to TC-1 cells (Fig. 5A). In
fibroblasts derived from fat-1 mice, the extent of MMP-9
induction was lower than that in fibroblasts from wild type mice
(Fig.5A). MMP-9 was not expressed in homotypic TC-1 cells,
consistent with immunohistochemical data from our in vivo
model. Furthermore, we confirmed that MMP-9 was not
expressed in the TC-1 cells by using a transwell co-culture model
(Fig. S2). Therefore, MMP-9 in the co-culture condition was
derived not from TC-1 cells but from fibroblasts. MMP-2
gelatinase activity was detected in all cell culture conditions,
including homotypic TC-1 cell cultures, and was not altered by co-
culture conditions (Fig 5B, 5D). MMP-9 gelatinase activities were,
however, detectable in fibroblast-TC-1 cell co-cultures, although
MMP-9 gelatinase activity involving fat-1 fibroblasts was clearly
suppressed when compared with wild type fibroblasts (Fig 5B, 5C),
again supporting the concept that MMP-9 expression and
gelatinase activity are suppressed by endogenous omega-3 PUFAs
in CAFs derived from fat-1 mice.
Discussion
In this study, we examined the involvement of defined dietary
factors (omega-3 and omega-6 PUFAs) in tumorigenesis using
HPV-positive TC-1 cells and proposed a novel anti-tumor
mechanism for omega-3 PUFAs that depends on the activities of
CAFs. Omega-3 PUFAs have been shown to suppress cancer
incidence and growth in various types of cancers [18,19,27]. Many
studies have demonstrated that omega-3 PUFAs have these effects
through anti-inflammatory responses directly and/or indirectly
[25–27] as well as through inducing tumor cell apoptosis and/or
suppressing tumor cell proliferation [18,19]. However, there have
been few reports about the effects of omega-3 PUFAs on CAFs.
CAFs have been implicated in facilitating the growth of several
tumors by directly stimulating tumor cell proliferation and by
enhancing angiogenesis [34,35]. Targeting genes and signaling
pathways mediating interaction of CAFs and tumor-microenvi-
ronment are considered to be essential for development of new
and effective cancer therapies [36,37]. In this study, using fat-1
mice and TC-1 tumor cells, we were able to clarify the effect of
omega-3 PUFA-rich CAFs on tumorigenesis.
Many molecules, including growth factors, cytokines, and
MMPs, play stimulatory and inhibitory roles in promoting
angiogenesis [21]. We investigated gene expression of angiogen-
esis-related cytokines, growth factors and MMPs in the TC-1
tumors of fat-1 and wild type mice by cDNA microarray. The
expression levels of almost all inflammatory cytokines/chemokines
and growth factors in TC-1 tumors from fat-1 mice were higher
than those in tumors from wild-type controls. In contrast, EGF
and MMP-2 and -9 expression levels in fat-1 mice were lower than
those in wild type mice. Since down-regulation of EGF in TC-1
tumors from fat-1 mice was predicted to promote TC-1 cell
proliferation but tumor size in fat-1 mice was significantly smaller
than in wild-type controls, we hypothesize that differences in
MMP production between fat-1 and wild type mice may be
responsible for the suppression of TC-1 tumor growth. Our in
vitro data verified that MMP-9 derived from CAFs activated by
TC-1 cell exposure was downregulated in the fat-1 mice. MMPs
are reported to influence tumor progression by facilitating events
pivotal for neovascularization and for the establishment of distant
metastasis including proliferation, survival and migration of
endothelial, tumor and stromal cells [8,9]. MMP inhibitors reduce
angiogenesis, tumor number, and tumor growth, as does genetic
ablation of MMP-9 [38]. In contrast to MMP-2, which is
constitutively expressed, MMP-9 levels are usually low and
enzyme expression is induced by cytokines that stimulate NF-kB
[8,39]. Furthermore, elevated serum and tissue levels of MMP-9
are reported to be associated with cancer invasion and metastasis
[40]. In breast cancer, MMP-9 activity has been localized around
CAFs and CAFs co-cultured with cancer cells which secrete TGF-
b, TNF-a, and other cytokines, increase production of MMP-9
[11], consistent with our in vitro data. In our data, suppression of
MMP-9 would contribute to accompany hypo-angiogenesis in the
tumor stromal component in fat-1 tumor.
Several transcription factors, including activator protein-1 (AP-
1), Sp-1, and NF-kB, are reported to be involved in alterations in
MMP-9 expression following exposure to various cytokines [41–
43]. Conversely, several reports have demonstrated that omega-3
PUFAs have an inhibitory effect on the NF-kB pathway when
activated by various stimuli [43–47]. Our own data suggest that
activation of the NF-kB pathway upon co-culture with TC-1 cells
may be suppressed by elevated level of omega-3 PUFAs in
fibroblast obtained from fat-1 mice.
In our experiments, we consistently used primary fibroblasts
that had been passaged 3-4 times only. Nevertheless, lipid
mediator analysis of the fibroblasts revealed that those derived
from fat-1 mice produced larger amounts of omega-3 PUFAs
including EPA-derived metabolites when compared with those
Figure 4. MMP-9 expression and enzymatic activity in primary-
cultured fibroblasts. (A) Primary fibroblasts isolated from murine
lungs were cultured. Total RNA from fibroblasts was reverse transcribed
and MMP-9 mRNA levels were measured by qRT-PCR. Expression levels
of MMP-9 were normalized to b-actin as an internal standard. Data are
the representative of three independent experiments. The data were
analyzed by using the Student’s t-test. Asterisks indicate those
comparisons (fat-1 vs. wild type (WT) mice) with statistical significance
(p,0.05). (B) Gelatin zymography: Supernatant from primary fibroblast
cultures were collected and separated by electrophoresis. Gelatinase
activities were visualized by standard staining techniques.
doi:10.1371/journal.pone.0089605.g004
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derived from wild type controls (Fig.S3), confirming that the
cultured fibroblasts retained the characteristic to make omega-3
PUFA rich environment.
TC-1 tumor microarray data showed that several inflammatory
cytokines/chemokines and growth factors were upregulated in fat-
1 mice. However, the data indicated gene expression levels in both
TC-1 cells and stromal components, including fibroblasts,
endothelial and immune cells. Therefore, expression levels of
each cytokine/chemokine were dependent on their primary
sources of production. MMP-9 was produced by the fibroblasts
derived from fat-1 mice but not by TC-1 cells. Therefore,
suppression of the NF-kB pathway by elevated levels of omega-3
PUFAs in fat-1-derived stromal components may have a specific
and potent effect on MMP-9 expression levels when compared
with the other inflammatory cytokines/chemokines. On the other
hand, a previous study demonstrates that omega-3 PUFAs activate
NK cells and increase proportions of activated CD8+ cells; this is
followed by enhanced anti-tumor effects [48]. Therefore, omega-3
PUFAs may exert both anti-inflammatory and pro-inflammatory
effects on immune cells.
In this study, we have demonstrated that an omega-3 PUFAs-
rich microenvironment can suppress MMP-9 secretion from CAFs
and that this is associated with subsequent tumor hypo-angiogen-
esis. This study proposes a novel anti-tumor effect of omega-3
PUFAs by modulating tumor microenvironment especially on
CAFs.
Supporting Information
Figure S1 Expression levels of E6 and E7 mRNA in TC-1
tumor. Total RNA was extracted from TC-1 tumors, followed by
reverse transcription. E6 and E7 mRNA levels were measured by
qRT-PCR. Expression levels of E6 and E7 mRNA were
normalized to b-actin as an internal standard. The E6 primers
were forward, 5’- TGCACAGAGCTGCAAACAAC -3’, and
reverse, 5’- AGCATATGGATTCCCATCTC -3’. The E7
primers were forward, 5’- TTTGCAACCAGAGACAACTGA -
3’, and reverse, 5’- GCCCATTAACAGGTCTTCCA -3’.
(TIF)
Figure S2 MMP-9 mRNA was not induced from TC-1
cells by co-culture with fibroblasts. 150 mL of suspensions
(26106/mL) of TC-1 cells or fibroblasts were added to the upper
chamber, 500 mL of suspensions (16105/mL) of TC-1 cells or
fibroblasts were added to the lower chamber of the 24 well
Transwell plates (1 mm pore) and placed in an incubator with 5%
CO2 at 37uC for 24 h and expression levels of MMP-9 in the TC-
1 or fibroblasts in the lower chamber were measured by RT-
qPCR. N.D. indicates ‘not detected’.
(TIF)
Figure S3 Lipid mediator analysis of fibroblast/TC-1 co-
cultured medium. Supernatants from fibroblast/TC-1 co-
cultures were collected and LC-MS/MS-based mediator lipido-
mics was performed on Acquity UPLC BEH C18 column
(1.0 mm6150 mm61.7 mm) using Acquity UltraPerformance
LC system (Waters Co.) coupled to an electrospray (ESI) triple
quadrupole mass spectrometer (QTRAP5500; AB SCIEX). The
MS/MS analyses were performed in negative ion mode, and the
eicosanoids and docosanoids were identified and quantified by
multiple reaction monitoring. Calibration curves between 1 and
1000 pg and the LC retention times for each compounds were
constructed with synthetic standards.
(TIF)
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Figure 5. The increased MMP-9 expression and activity in TC-1/fibroblast co-cultures is inhibited in fat-1 mice. (A) Isolated fibroblasts
were co-cultured with TC-1 cells for 24 hours and expression levels of MMP-9 in the fibroblasts were measured by RT-qPCR. Expression levels of MMP-
9 were normalized to b-actin as an internal standard. The data are representative of three independent experiments. The data were analyzed using
the Student’s t-test. Asterisks indicate those comparisons (fat-1 vs. wild type (WT) mice) with statistical significance (p,0.05). ‘‘N.D.’’ indicates ‘not
detected’. (B) Gelatin zymography: Supernatants from fibroblast homotypic cultures and fibroblast/TC-1 co-cultures were collected and separated by
electrophoresis. Gelatinase activities were visualized by standard staining techniques. (C, D) For semi-quantitative analyses, gelatin zymography
bands were analyzed using image analysis software. Results are represented as mean 6SEM of three independent experiments. The data were
analyzed using the Student’s t-test. Asterisks indicate those comparisons (fat-1 vs. wild type (WT) mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0089605.g005
MMP-9 in CAFs Is Suppressed by Omega-3 PUFAs
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e89605
Author Contributions
Conceived and designed the experiments: AT K. Kawana KT AY MA K.
Koga. Performed the experiments: AT K. Kawana KT AY YI KN TI HN
SK YM. Analyzed the data: AT K. Kawana KT AY K. Koga TA KA OW
KO HA MA JK TF YO. Contributed reagents/materials/analysis tools:
AT KT AY. Wrote the paper: AT K. Kawana MA.
References
1. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution
to tumor evolution toward metastasis, Histochem Cell Biol, 130:1091–1103
2. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis, Nat
Rev Cancer, 9:239–252
3. Franco OE, Shaw AK, Strand DW, Hayward SW (2010) Cancer associated
fibroblasts in cancer pathogenesis, Semin Cell Dev Biol, 21:33–39
4. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer, Nat Rev Cancer, 6:392–401
5. Schauer IG, Zhang J, Xing Z, Guo X, Mercado-Uribe I, et al (2013) Interleukin-
1beta promotes ovarian tumorigenesis through a p53/NF-kappaB-mediated
inflammatory response in stromal fibroblasts, Neoplasia, 15:409–420
6. Zhu Y, Zhu M, Lance P (2012) IL1beta-mediated Stromal COX-2 signaling
mediates proliferation and invasiveness of colonic epithelial cancer cells, Exp
Cell Res, 318:2520–2530
7. Jones CB, Sane DC, Herrington DM (2003) Matrix metalloproteinases,
Cardiovas Res, 59:812–823
8. Lynch CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell
communication, Differentiation, 70:561–573
9. Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, et al (2004) Stromal
Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblas-
toma by Promoting Pericyte Recruitment, Cancer Res, 64:1675–1686
10. Roomi MW, Monterrey JC, Kalinovsky T, Niedzwiecki A, Rath M (2009)
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in
lung cancer and malignant mesothelioma cell lines, Oncol Rep, 22:1283–1291
11. Stuelten CH, Byfield SD, Arany PR, Karpova TS, Stetler-Stevenson WG, et al
(2005) Breast cancer cells induce stromal fibroblasts to express MMP-9 via
secretion of TNF-a and TGF-b, Journal of Cell Sci, 118:2143–2153
12. Genersch E, Hayess K, Neuenfeld Y, Haller H (2000) Sustained ERK
phosphorylation is necessary but not sufficient for MMP-9 regulation in
endothelial cells: involvement of Ras-dependent and -independent pathways, J
Cell Sci, 113 Pt 23:4319–4330
13. Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z (2003) Angiogenesis:
vascular remodeling of the extracellular matrix involves metalloproteinases,
Current Opinion in Hematol, 10:136–141
14. Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs
the end, Nat Immunol, 6:1191–1197
15. Hardman WE (2002) Omega-3 fatty acids to augment cancer therapy, J Nutr,
132:3508S–3512S
16. Lee CY, Sit WH, Fan ST, Man K, Jor IW, et al (2010) The cell cycle effects of
docosahexaenoic acid on human metastatic hepatocellular carcinoma prolifer-
ation, Int J Oncol, 36:991–998
17. Habermann N, Schon A, Lund EK, Glei M (2010) Fish fatty acids alter markers
of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish
consumption has no impact on apoptosis-induction ex vivo, Apoptosis, 15:621–
630
18. Serini S, Piccioni E, Merendino N, Calviello G (2009) Dietary polyunsaturated
fatty acids as inducers of apoptosis: implications for cancer, Apoptosis, 14:135–
152
19. Field CJ, Schley PD (2004) Evidence for potential mechanisms for the effect of
conjugated linoleic acid on tumor metabolism and immune function: lessons
from n-3 fatty acids, Am J Clin Nutr, 79:1190S–1198S
20. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, et al (2004) n-3
PUFAs reduce VEGF expression in human colon cancer cells modulating the
COX-2/PGE2 induced ERK-1 and -2 and HIF-1a induction pathway,
Carcinogenesis, 25:2303–2310
21. Spencer L, Mann C, Metcalfe M, Webb MB, Pollard C, et al (2009) The effect
of omega-3 FAs on tumour angiogenesis and their therapeutic potential, Eur j
cancer, 45:2077–2086
22. Rose DP, Connolly JM (1999) Antiangiogenicity of docosahexaenoic acid and its
role in the suppression of breast cancer cell growth in nude mice, Int J Oncol,
15:1011–1015
23. Mukutmoni-Norris M, Hubbard NE, Erickson KL (2000) Modulation of murine
mammary tumor vasculature by dietary n-3 fatty acids in fish oil, Cancer Lett,
150:101–109
24. Tevar R, Jho DH, Babcock T, Helton WS, Espat NJ (2002) Omega-3 fatty acid
supplementation reduces tumor growth and vascular endothelial growth factor
expression in a model of progressive non-metastasizing malignancy, JPEN J
Parenter Enteral Nutr, 26:285–289
25. Kang JX (2007) Fat-1 transgenic mice: a new model for omega-3 research,
Prostaglandins Leukot Essent Fatty Acids, 77:263–267
26. Kang JX, Wang J, Wu L, Kang ZB (2004) Transgenic mice: fat-1 mice convert
n-6 to n-3 fatty acids, Nature, 427:504
27. Xia S, Lu Y, Wang J, He C, Hong S, et al (2006) Melanoma growth is reduced
in fat-1 transgenic mice: Impact of omega-6/omega-3 essential fatty acids,
PNAS, 103:12499–12504
28. Nowak J, Weylandt KH, Habbel P, Wang J, Dignass A, et al (2007) Colitis-
associated colon tumorigenesis is suppressed in transgenic mice rich in
endogenous n-3 fatty acids, Carcinogenesis, 28:1991–1995
29. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, et al (2008) Reduced
Colitis-Associated Colon Cancer in Fat-1 (n-3 Fatty Acid Desaturase) Transgenic
Mice, Cancer Res, 68:3985–3991
30. Weylandt KH, Krause LF, Gomolka B, Chiu C-Y, Bilal S, et al (2011)
Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is
associated with increased omega-3 derived lipid mediators and reduced TNF-a,
Carcinogenesis, 32:897–903
31. zur Hausen H (2009) Papillomaviruses in the causation of human cancers — a
brief historical account, Virology, 384:260–265
32. Lin KY, Guarnieri FG, Staveley-O’Carroll KF, Levitsky HI, August JT, et al
(1996) Treatment of established tumors with a novel vaccine that enhances
major histocompatibility class II presentation of tumor antigen, Cancer Res,
56:21–26
33. Rowe RG, Keena D, Sabeh F, Willis AL, Weiss SJ (2011) Pulmonary fibroblasts
mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to
destructively remodel and invade interstitial type I collagen barriers, Am J
Physiol Lung Cell Mol Physiol, 301:L683–692
34. Erez N, Truitt M, Olson P, Arron ST, Hanahan D (2010) Cancer-Associated
Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-
Promoting Inflammation in an NF-kappaB-Dependent Manner, Cancer Cell,
17:135–147
35. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer
initiation and progression, Nature, 432:332–337
36. Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells
recruited to the tumor microenvironment, Cancer Cell, 21:309–322
37. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and
evolving paradigms, Cell, 147:275-292
38. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, et al (2000) Matrix
metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat
Cell Biol, 2:737–744
39. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell
behavior, Annu Rev Cell Dev Biol, 17:463–516
40. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metallopro-
teinases in tumor invasion: role for cell migration, Pathol Int, 52:255–264
41. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, et al (2000) Matrix
metalloproteinase 9 promoter activity is induced coincident with invasion during
tumor progression, Am J Pathol, 157:1777–1783
42. Simon C, Simon M, Vucelic G, Hicks MJ, Plinkert PK, et al (2001) The p38
SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-
dependent promoter activation, Exp Cell Res, 271:344–355
43. Kim HH, Lee Y, Eun HC, Chung JH (2008) Eicosapentaenoic acid inhibits
TNF-alpha-induced matrix metalloproteinase-9 expression in human keratino-
cytes, HaCaT cells, Biochem Biophys Res Commun, 368:343–349
44. Mishra A, Chaudhary A, Sethi S (2004) Oxidized omega-3 fatty acids inhibit
NF-kappaB activation via a PPARalpha-dependent pathway, Arterioscler
Thromb Vasc Biol, 24:1621–1627
45. Dichtl W, Ares MP, Jonson AN, Jovinge S, Pachinger O, et al (2002) Linoleic
acid-stimulated vascular adhesion molecule-1 expression in endothelial cells
depends on nuclear factor-kappaB activation, Metabolism, 51:327–333
46. Zhao Y, Joshi-Barve S, Barve S, Chen LH (2004) Eicosapentaenoic acid
prevents LPS-induced TNF-alpha expression by preventing NF-kappaB
activation, J Am Coll Nutr, 23:71–78
47. Ross JA, Maingay JP, Fearon KC, Sangster K, Powell JJ (2003) Eicosapentae-
noic acid perturbs signalling via the NFkappaB transcriptional pathway in
pancreatic tumour cells, Int J Oncol, 23:1733–1738
48. Robinson LE, Clandinin MT, Field CJ (2002) The role of dietary long-chain n-3
fatty acids in anti-cancer immune defense and R3230AC mammary tumor
growth in rats: influence of diet fat composition, Breast Cancer Res Treat,
73:145–160
MMP-9 in CAFs Is Suppressed by Omega-3 PUFAs
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e89605
